Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Authors
Keywords
Non receptor tyrosine kinases, hematological malignancy, signaling pathways, natural products
Journal
Molecular Cancer
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-15
DOI
10.1186/s12943-018-0788-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
- (2017) Elena Tibaldi et al. HAEMATOLOGICA
- Structure–Activity Relationship of Curcumin: Role of the Methoxy Group in Anti-inflammatory and Anticolitis Effects of Curcumin
- (2017) Haixia Yang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
- (2017) Pablo Angulo et al. Journal of Hematology & Oncology
- Syk inhibitors in clinical development for hematological malignancies
- (2017) Delong Liu et al. Journal of Hematology & Oncology
- Focal Adhesion Kinase as a Potential Target in AML and MDS
- (2017) Bing Z. Carter et al. MOLECULAR CANCER THERAPEUTICS
- Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion
- (2017) Tereza Vanova et al. STEM CELLS
- Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
- (2017) Elena Tibaldi et al. HAEMATOLOGICA
- Interleukin-2-inducible T-cell kinase expression and relation to disease severity in systemic lupus erythematosus
- (2016) Wang-Dong Xu et al. CLINICA CHIMICA ACTA
- Multifunctional Abl kinases in health and disease
- (2016) Aaditya Khatri et al. JOURNAL OF CELL SCIENCE
- Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
- (2016) Yasmin Rosshandler et al. Expert Review of Hematology
- Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms
- (2016) Chaolan Lv et al. MEDICAL SCIENCE MONITOR
- Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation
- (2015) Xin-pin Wu et al. ACTA PHARMACOLOGICA SINICA
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A
- (2015) F. Zonta et al. BLOOD
- Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach
- (2015) A. Nonami et al. BLOOD
- Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis
- (2015) J. E. Maxson et al. CANCER RESEARCH
- JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
- (2015) L. Springuel et al. HAEMATOLOGICA
- ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling
- (2015) BINHUI XIE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
- (2015) Yiming Zhong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling
- (2015) Song-Hui Xu et al. JOURNAL OF PATHOLOGY
- Src family kinases and their role in hematological malignancies
- (2015) Matthew Ku et al. LEUKEMIA & LYMPHOMA
- Fyn is an important molecule in cancer pathogenesis and drug resistance
- (2015) Daniel Elias et al. PHARMACOLOGICAL RESEARCH
- Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling
- (2015) Aysun Adan et al. TUMOR BIOLOGY
- JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
- (2015) L. Springuel et al. HAEMATOLOGICA
- Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
- (2014) X. Li et al. ARCHIVES OF TOXICOLOGY
- High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia
- (2014) Rabab M. Aly et al. BLOOD CELLS MOLECULES AND DISEASES
- An overview of FDA-approved new molecular entities: 1827–2013
- (2014) Michael S. Kinch et al. DRUG DISCOVERY TODAY
- Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia
- (2014) C. Gattazzo et al. HAEMATOLOGICA
- Acute Myeloid Leukemia with BCR/ABL Fusion Chimera
- (2014) Manoj Madashira Gopal et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Mechanisms of Gambogic Acid-Induced Apoptosis in Non-Small Cell Lung Cancer Cells in Relation to Transferrin Receptors
- (2014) Xiaoli Zhu et al. JOURNAL OF CHEMOTHERAPY
- Homoharringtonine and omacetaxine for myeloid hematological malignancies
- (2014) Shuqing Lü et al. Journal of Hematology & Oncology
- The Tec Kinases Itk and Rlk Regulate NKT Cell Maturation, Cytokine Production, and Survival
- (2014) M. Felices et al. JOURNAL OF IMMUNOLOGY
- Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia
- (2014) Gege Feng et al. LEUKEMIA & LYMPHOMA
- Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism
- (2014) GANG ZHANG et al. Molecular Medicine Reports
- Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells
- (2014) Soner Solmaz et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers
- (2014) K Mahajan et al. ONCOGENE
- The SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility
- (2014) Allan Joaquim Lamontanara et al. Nature Communications
- Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice
- (2013) GY Li et al. Advances in Medical Sciences
- Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
- (2013) J. Cortes et al. AMERICAN JOURNAL OF HEMATOLOGY
- ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation
- (2013) Kiran Mahajan et al. CANCER LETTERS
- Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic Leukemia
- (2013) S. Bunda et al. CANCER RESEARCH
- Molecular Pathways: Targeting the Microenvironment in Chronic Lymphocytic Leukemia—Focus on the B-Cell Receptor
- (2013) Elisa ten Hacken et al. CLINICAL CANCER RESEARCH
- Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation
- (2013) X. Shi et al. CLINICAL CANCER RESEARCH
- Ibrutinib and Indolent B-Cell Lymphomas
- (2013) Akintunde Akinleye et al. Clinical Lymphoma Myeloma & Leukemia
- A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome
- (2013) N. Daver et al. EUROPEAN JOURNAL OF CANCER CARE
- Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors
- (2013) F. E. Nicolini et al. HAEMATOLOGICA
- Structure and Dynamic Regulation of Abl Kinases
- (2013) Shoghag Panjarian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Importance of microbial natural products and the need to revitalize their discovery
- (2013) Arnold L. Demain JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
- (2013) A Bouchekioua et al. LEUKEMIA
- Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
- (2013) Hirotoshi Sakaguchi et al. NATURE GENETICS
- TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia
- (2013) Takaomi Sanda et al. Cancer Discovery
- Gambogic acid activates AMP-activated protein kinase in mammalian cells
- (2012) Baobing Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers
- (2012) Nancy L. Cho et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
- (2012) J. Cortes et al. BLOOD
- Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation
- (2012) Marie-Magdelaine Coude et al. BRITISH JOURNAL OF HAEMATOLOGY
- Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway
- (2012) Yong Guo et al. CANCER BIOLOGY & THERAPY
- p120RasGAP-Mediated Activation of c-Src Is Critical for Oncogenic Ras to Induce Tumor Invasion
- (2012) P.-C. Chan et al. CANCER RESEARCH
- Small-Molecule Inhibitors of the c-Fes Protein-Tyrosine Kinase
- (2012) Sabine Hellwig et al. CHEMISTRY & BIOLOGY
- Studies on gambogic acid (IV): Exploring structure–activity relationship with IκB kinase-beta (IKKβ)
- (2012) Haopeng Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of the Src Family Kinases by Csk
- (2012) Masato Okada International Journal of Biological Sciences
- The Role of the Tec Kinase Bruton's Tyrosine Kinase (Btk) in Leukocyte Recruitment
- (2012) Helena Block et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis
- (2012) Xiao-hua Xu et al. Journal of Zhejiang University-SCIENCE B
- Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia
- (2012) T Bains et al. LEUKEMIA
- SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias
- (2012) Bernard Bourrié et al. LEUKEMIA & LYMPHOMA
- Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
- (2012) Sangkil Nam et al. Molecular Oncology
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms
- (2012) Zhao-Li Zhou et al. NATURAL PRODUCT REPORTS
- BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
- (2012) Oliver Hantschel et al. Nature Chemical Biology
- JAK/STAT signaling in hematological malignancies
- (2012) W Vainchenker et al. ONCOGENE
- Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia
- (2012) Melissa M. Singh et al. PLoS One
- Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells
- (2012) P. W. Bryant et al. Biology Open
- Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
- (2011) F. Condorelli et al. CURRENT MEDICINAL CHEMISTRY
- The Syk kinase as a therapeutic target in leukemia and lymphoma
- (2011) Dimitar G Efremov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Tyrosine Kinase BMX Is an Essential Mediator of Inflammatory Arthritis in a Kinase-Independent Manner
- (2011) M. Gottar-Guillier et al. JOURNAL OF IMMUNOLOGY
- Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
- (2011) J Congleton et al. LEUKEMIA
- Focal adhesion kinase as a target in the treatment of hematological malignancies
- (2011) Bu Yin LEUKEMIA RESEARCH
- High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells
- (2011) M. C. Henderson et al. MOLECULAR CANCER RESEARCH
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systems biology of JAK-STAT signalling in human malignancies
- (2011) Julio Vera et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
- (2011) Siyuan Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
- (2011) David DeRemer et al. Cancer Management and Research
- ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon
- (2010) T. Hornakova et al. BLOOD
- Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib
- (2010) W. Deenik et al. BLOOD
- Fyn
- (2010) Yoshihito D. Saito et al. CANCER
- Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
- (2010) E. L. Mayer et al. CLINICAL CANCER RESEARCH
- The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge
- (2010) Franck E. Nicolini et al. Clinical Lymphoma Myeloma & Leukemia
- An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro
- (2010) Rong Mu et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner
- (2010) Teodora Pene-Dumitrescu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Shepherding AKT and androgen receptor by Ack1 tyrosine kinase
- (2010) Kiran Mahajan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- FES kinases are required for oncogenic FLT3 signaling
- (2010) E Voisset et al. LEUKEMIA
- The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy
- (2010) Yu-Feng Li et al. LEUKEMIA & LYMPHOMA
- Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
- (2010) Zhongzheng Lu et al. Molecular Cancer
- Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation
- (2010) Kiran Mahajan et al. PLoS One
- ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
- (2010) J. Colicelli Science Signaling
- Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
- (2010) Stella Chai et al. Chinese Medicine
- Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
- (2009) Yan-lin Wei et al. ACTA PHARMACOLOGICA SINICA
- The Antiproliferation Effect of Berbamine on K562 Resistant Cells by Inhibiting NF-κB Pathway
- (2009) Yan-Lin Wei et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies
- (2009) Kais Hussein et al. ANNALS OF HEMATOLOGY
- Syk and pTyr'd: Signaling through the B cell antigen receptor
- (2009) Robert L. Geahlen BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Celastrol, a novel HSP90 inhibitor, depletes Bcr–Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation
- (2009) Zhongzheng Lu et al. CANCER LETTERS
- Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation
- (2009) X. Shi et al. CLINICAL CANCER RESEARCH
- NF-κB regulates the transcription of protein tyrosine kinase Tec
- (2009) Liang Yu et al. FEBS Journal
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk
- (2009) Julie A. Readinger et al. IMMUNOLOGICAL REVIEWS
- Effect of Haishengsu as an Adjunct Therapy for Patients with Advanced Renal Cell Cancer: A Randomized and Placebo-Controlled Clinical Trial
- (2009) Ji-Zhu Liu et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells
- (2009) Yin Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice
- (2009) Y Chen et al. LEUKEMIA
- Kinase mutations in human disease: interpreting genotype–phenotype relationships
- (2009) Piya Lahiry et al. NATURE REVIEWS GENETICS
- Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues
- (2009) Sermin Ozkal et al. PATHOLOGY RESEARCH AND PRACTICE
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
- (2009) Chunlei Wu et al. GENOME BIOLOGY
- Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells
- (2008) Audrey Sirvent et al. BIOLOGY OF THE CELL
- Health care reform in Chile
- (2008) G. Bastias et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804
- (2008) Richard M. Stone et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: A pilot randomized and placebo-controlled clinical trial
- (2008) Guang-Yao Li et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells
- (2008) Hongyan Tong et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Dysregulation of Ack1 inhibits down-regulation of the EGF receptor
- (2008) Lene Melsæther Grøvdal et al. EXPERIMENTAL CELL RESEARCH
- Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia
- (2008) Basem M. William et al. Hematology
- A crucial role in cell spreading for the interaction of Abl PxxP motifs with Crk and Nck adaptors
- (2008) S. Antoku et al. JOURNAL OF CELL SCIENCE
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tyrosine Phosphorylation in the SH3 Domain Disrupts Negative Regulatory Interactions within the c-Abl Kinase Core
- (2008) Shugui Chen et al. JOURNAL OF MOLECULAR BIOLOGY
- JAKandMPLmutations in myeloid malignancies
- (2008) Ayalew Tefferi LEUKEMIA & LYMPHOMA
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The JAK kinases: Not just another kinase drug discovery target
- (2008) Andrew F. Wilks SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mining for JAK–STAT mutations in cancer
- (2008) Stefan N. Constantinescu et al. TRENDS IN BIOCHEMICAL SCIENCES
- Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
- (2007) Z. Xiang et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More